Drug Shortage Report for TEVA-PREGABALIN
| Report ID | 29456 |
| Drug Identification Number | 02361159 |
| Brand name | TEVA-PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-11-16 |
| Estimated end date | 2018-01-19 |
| Actual end date | 2018-02-15 |
| Shortage status | Resolved |
| Updated date | 2018-02-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-02-21 | French | Compare |
| v4 | 2018-02-21 | English | Compare |
| v3 | 2017-11-17 | English | Compare |
| v2 | 2017-11-16 | French | Compare |
| v1 | 2017-11-16 | English | Compare |
Showing 1 to 5 of 5